← Back to Clinical Trials
Recruiting NCT07309796

NCT07309796 Strengthening Exercises for Humeral Head Depressor Muscles

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07309796
Status Recruiting
Phase —
Sponsor Hacettepe University
Condition Reverse Shoulder Arthroplasty
Study Type INTERVENTIONAL
Enrollment 27 participants
Start Date 2026-01-02
Primary Completion 2026-09-02

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
Conventional Rehabilitation GroupDepressor Muscle Strengthening Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 27 participants in total. It began in 2026-01-02 with a primary completion date of 2026-09-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Postoperative rehabilitation after reverse shoulder arthroplasty aims to improve pain control, range of motion, and functional capacity. However, studies examining the effects of strengthening exercises targeting the humeral head depressor muscles are limited. This randomized controlled trial will evaluate the effects of adding a specific strengthening program to standard rehabilitation on pain, range of motion, quality of life, and functional outcomes.

Eligibility Criteria

Inclusion Criteria: * Patients scheduled for primary reverse total shoulder arthroplasty Intact teres minor confirmed by physical examination (Hornblower's test) and intraoperative assessment Ability to participate in physiotherapy or a home exercise program Exclusion Criteria: * Active infection Deltoid muscle insufficiency Inability or unwillingness to comply with randomization Prior shoulder arthroplasty on the same side Unwillingness to participate Inability to read or understand written instructions

Contact & Investigator

Central Contact

Caner KARARTI, Assoc. Prof.

✉ fzt.caner.92@gmail.com

📞 903862805362

Frequently Asked Questions

Who can join the NCT07309796 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Reverse Shoulder Arthroplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07309796 currently recruiting?

Yes, NCT07309796 is actively recruiting participants. Contact the research team at fzt.caner.92@gmail.com for enrollment information.

Where is the NCT07309796 trial being conducted?

This trial is being conducted at Kırşehir, Turkey (Türkiye).

Who is sponsoring the NCT07309796 clinical trial?

NCT07309796 is sponsored by Hacettepe University. The trial plans to enroll 27 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology